News & Highlights
Drew Armstrong of Bloomerg covered results from recent study looking at men whose prostate cancer relapsed and delayed hormone theraphy treatment.
UCSF researchers make an important scientific breakthrough that connects two fundamental cellular processes, protein synthesis and metabolism, important for fueling cancer cell growth. Remarkably, the targeted inhibition of this specific connection caused cancer cells but not normal cells to die, therefore identifying an attractive new approach to cancer therapy.
Study offers new data on hormone therapy timing strategies when prostate cancer relapse is detected by rising PSA levels alone.
The American Association of Genitourinary Surgeons awarded its 2014 Barringer Medal to Peter R. Carroll, MD, MPH, chair of the UCSF Department of Urology ...
Dr. Maurice Garcia, MD, MAS, Assistant Professor of Urology, UCSF designed and developed an implantable fiducial marker for the bladder that allows Radiation Oncologists to visualize and target the tumor site with high-dosages of radiotherapy, and is spearheading ongoing research to develop their role in clinical treatment.
The highly regarded Elsevier practiceupdate.com site recently sought expert commentary from UCSF Urology Chair, Peter Carroll, MD, MPH, for elucidation on results from the Scandinavian Prostate Cancer Study...
Greenbrae, CA, January 28, 2013—Peter R.
Filter By Topic
Filter by Date
We are so excited to have you join us for UCSFUrology's next Grand Rounds, July 8th 7am PST, "High-Impact publishin… t.co/vRub0r9SBV
UCSFUrology's Alan Shindel, MD, MAS chaired panel for newly released guidelines on ejaculatory disorders t.co/sSNcSP3A3r
Drs Carroll, Chu and Lonergan congratulate Stavrinides and colleagues on the outcomes reported for magnetic resona… t.co/xVsrtIKuON